Travere Therapeutics (TVTX) Income After Tax (2011 - 2026)
Travere Therapeutics' Income After Tax was -$61.04 million in Q3 2026, compared with $25.71 million a year earlier.
Powered by 
Analysis
Travere Therapeutics (TVTX) Income After Tax (2011 - 2026) Analysis & Trends
On a trailing twelve-month basis, Travere Therapeutics' Income After Tax was -$154.42 million through Sep 30, 2026; for FY2025, it was -$50.26 million.
- In earlier years, Income After Tax was -$320.63 million in FY2024, -$376.33 million in FY2023, -$331.47 million in FY2022 and -$217.29 million in FY2021.
- The Q3 2026 figure marks the lowest quarterly Income After Tax since Q2 2024.
- Per Business Quant data, TVTX's Income After Tax in the three quarters before Q3 2026 was -$34.8 million (Q2 2026), -$36.6 million (Q1 2026) and -$21.99 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income After Tax (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.80 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.25 Bn |
| 10 | Travere Therapeutics | 4.97 Bn | 4.56 Bn | 221.70 Mn | -61.04 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -61.04 Mn |
| Jun 30, 2026 | -34.80 Mn |
| Mar 31, 2026 | -36.60 Mn |
| Dec 31, 2025 | -21.99 Mn |
| Sep 30, 2025 | 25.71 Mn |
| Jun 30, 2025 | -12.76 Mn |
| Mar 31, 2025 | -41.23 Mn |
| Dec 31, 2024 | -60.27 Mn |
| Sep 30, 2024 | -54.75 Mn |
| Jun 30, 2024 | -69.65 Mn |
| Mar 31, 2024 | -135.96 Mn |
| Dec 31, 2023 | -88.60 Mn |
| Sep 30, 2023 | -89.24 Mn |
| Jun 30, 2023 | -101.93 Mn |
| Mar 31, 2023 | -96.56 Mn |
| Dec 31, 2022 | -85.64 Mn |
| Sep 30, 2022 | -84.06 Mn |
| Jun 30, 2022 | -80.02 Mn |
| Mar 31, 2022 | -81.75 Mn |
| Dec 31, 2021 | -88.77 Mn |
API Access
Travere Therapeutics Income After Tax API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=profit-after-tax&ticker=TVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "profit-after-tax", "ticker": "TVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=profit-after-tax&ticker=TVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();